Turbocharging Your Next Gen LNP End-To-End Development to Deliver Quality Products to Patients Faster

April 17-19, 2023|Boston, MA

Accelerate Novel Lipid Discovery, Optimized Formulation & Tightened CQAs for Process Development to Achieve Scalability & Regulatory Compliance for Improved Product Quality & Widened Therapeutic Windows

Building on the success of our 2022 summit, we are bringing the inaugural LNP Formulation & Process Development Summit back and better than ever in 2023.

In April 2023, the 2nd Annual LNP Formulation & Process Development meeting is returning to Boston to welcome 350+ LNP Biology, Chemistry, Formulation & Process Development, Tech Ops & Manufacturing experts for sharing, learning and networking to turbocharge next generation of LNP development.

With expanded content, the 3-tracks summit will now offer the most comprehensive content, equipping you with end-to-end LNP development journey to exploit this lucrative non-viral delivery vehicle for various payloads to your destined cells and organs.

Join the ever-growing audience of LNP experts seeking to overcome the challenges of developing LNPs for a variety of applications and payloads, from discovery, formulation & process development, lipid supply and scale up manufacturing departments. 

Hear from likes of Omega Therapeutics, AstraZeneca, Pfizer, Beam Therapeutics, Alnylam Pharmaceuticals and more.

What to Expect at the 2nd Annual LNP Formulation & Process Development Summit:

60+
LNP Industry Trailblazers
350+
LNP Expert Attendees
3
Jam-Packed Days of Exclusive Content 
3
Tracks of Parallel Talks For You & Your Team 

2023 World-Class Speaker Faculty Includes:

Sakya Mohapatra

Director - Formulation Development

ReCode Therapeutics, Inc

John Androsavich

Head Of Global Ribonucleic Acid & Emerging Science Lead

Pfizer

Liping Zhou

Senior Director - Advanced Drug Delivery

AstraZeneca

Priya Karmali

Vice President, Technology Innovation and Development

Arcturus Therapeutics

Jeffrey Atkinson

Director - Executive, Process Development & Analytical Sciences

Omega Therapeutics

Lubomir Nechev

Senior Vice President - Chemistry, Manufacturing,Controls & Development

Alnylam Pharmaceuticals

Rahul Keswani

Associate Director, Non-Viral Gene Therapy

Arbor Biotechnologies

Russell Johnson

Vice President Formulation Research

RVAC Medicines

Hear What Our Speakers Say

"I am looking forward to connecting with expert researchers and industrial partners to discuss the fast growing LNP development landscape, from early discovery to regulatory strategies, in order to accelerate the access of life changing medicines to patients"

Marianna Yanez Arteta, Associate Director, AstraZeneca

"New trends in LNP as delivery systems: novel lipids, novel manufacturing techniques, new applications, LNP in therapeutics as opposed to vaccines"

Lubo Nechev, Senior Vice President CMC Development, Alnylam Pharmaceuticals

"To have a meeting that covers all aspects of LNP development – from discovery to scale-up – is immensely valuable"

Cory Sago, Former Senior Director, Head of LNP Discovery, Beam Therapeutics

Thank You To Our 2023 Partners:

Catalent_Biologics (2)
1
MERCK_MSIG_RPurple_RGB
03_英文マークNOF
LNP Speaker Logos (3)
KNAUER-LOGO-2022_CMYK-Blue
ardena logo
UNCHAINED LABS Logo
Helix Logo
eTheRNA
black_with_green_liposome
lipiod logo
Certest_Pharma
LOGO FINAL (3000 3000 px)
82
Cayman Horizontal Logo-RGB
phosphorex logo
Polysciences
2
FUJIFILM_Slogan
babffca6-e662-4777-b0f9-d93ea4aa4e43
6fac6aaf-391f-481e-8bf6-e489670494bd

Other Events in the Series: